Stem cell transplantation in patients with severe congenital neutropenia with evidence of leukemic transformationSung Won Choi, John E. Levine, Laurence A. Boxer et al.|Bone Marrow Transplantation|2005Cited by 49
Unrelated Donor Peripheral Blood Stem Cell (PBSC) Transplantation Using Nonmyeloablative Conditioning and Mycophenolate Mofetil (MMF) TID Results in High Engraftment Rates.Michael B. Maris, Rainer Storb, Brenda M. Sandmaier et al.|Blood|2004Cited by 7
Characterization of Extramedullary Disease (EMD) Response to CD19 Targeted Chimeric Antigen Receptor T-Cells (CART) in Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (B-ALL): A Multi-Site, Retrospective Cohort ReviewAlexander W. Rankin, Susan R. Rheingold, Daniel W. Lee et al.|Transplantation and Cellular Therapy|2024Cited by 4
Outcomes Following Matched Sibling Donor Transplant for Severe Combined Immunodeficiency: A Report from the PidtcAhmad Rayes, Christopher C. Dvorak, Brent R. Logan et al.|Transplantation and Cellular Therapy|2024Cited by 3
Allogeneic Hematopoietic Cell Transplantation (HCT) with Nonmyeloablative Conditioning after Failed Myeloablative HCT: Factors Affecting Outcomes.Frédéric Baron, Brenda M. Sandmaier, Rainer Storb et al.|Blood|2005Cited by 1